Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
11,957,539
-
Share change
-
-1,065,522
-
Total reported value
-
$90,132,346
-
Put/Call ratio
-
0%
-
Price per share
-
$7.54
-
Number of holders
-
33
-
Value change
-
-$7,504,039
-
Number of buys
-
14
-
Number of sells
-
19
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q4 2018
As of 31 Dec 2018 INTEC PHARMA LTD JERUSALEM - SHS had 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,957,539 shares of stock of the company.
Largest 10 holders included MEITAV DASH INVESTMENTS LTD, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Sectoral Asset Management Inc, Prosight Management, LP, Harel Insurance Investments & Financial Services Ltd., Migdal Insurance & Financial Holdings Ltd., DAFNA Capital Management LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, and Knott David M.
This table shows 33 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.